@asumono_krom RFdiffusion has produced experimentally validated protein binders, AI-designed rentosertib has reached randomized phase II trials for pulmonary fibrosis.
It can accelerate hypothesis generation, identify promising drug candidates, and help explore mechanisms to cut the cost.
SUNGUARD LIGHT SHELL - SGLS Mk.II
🎨 @AxonTatsu
Mk.II delivers lightweight protection without unnecessary bulk.
Designed for maximum mobility, all-day comfort, it functions as a low-profile protective shell for high-heat.
Minimal weight. Maximum coverage.
Mission-ready.